期刊文献+

COX-2抑制剂联合放疗对人乳腺癌裸鼠移植瘤作用的研究 被引量:2

Effects of COX-2 inhibitor combined with radiotherapy on xenograft tumor of breast cancer in nude mice
下载PDF
导出
摘要 目的观察环氧化酶-2(COX-2)抑制剂塞来昔布联合放疗对人乳腺癌MDA-MB-231细胞裸鼠移植瘤生长的影响。方法建立人乳腺癌裸鼠移植瘤模型,观察塞来昔布联合放疗治疗后裸鼠移植瘤的生长情况,测定移植瘤中COX-2、血管内皮生长因子(VEGF)的表达情况。结果塞来昔布联合放疗治疗后移植瘤的体积和重量减小(P<0.01),COX-2、VEGF表达下降(P<0.05)。结论塞来昔布联合放疗能抑制人乳腺癌裸鼠移植瘤的生长。 Objective To study the effects of COX-2 inhibitor combined with radiotherapy on xenograft tumor of breast cancer in nude mice.Methods To establish the breast cancer xenograft tumor modle in nude mice,and treated the tumor mice with radiotherapy combined celecoxib,then to detect the expression of COX-2,vascular endothelial growth factor(VEGF),and the growth of the xenograft tumor.Results After the treatment,the weight and the volume of the xenograft tumor decreased significantly(P0.01),the expression of COX-2 and VEGF decreased significantly(P0.05).Conclusion Radiotherapy combined celecoxib can significantly inhibit the growth of xenograft tumor.
出处 《山东医药》 CAS 北大核心 2011年第12期33-34,118,共3页 Shandong Medical Journal
基金 湖南省科技计划项目(2008FJ3086)
关键词 乳腺肿瘤 放疗 塞来昔布 环氧化酶-2 血管内皮生长因子 breast neoplasms radiotherapy clecoxib COX-2 vascular endothelial growth factor
  • 相关文献

参考文献7

  • 1Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes [J]. J Clin Invest, 2001,107(12) :1491-1495.
  • 2Stasinoponlos I, O'Brien DR, Wildes F, et al. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly dife rentiated metastatic breast cancer cells [ J ]. Mol Cancer Res, 2007, 5(5) :435-442.
  • 3Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and an titunor activities of cyclooxygenase-2 inhibitor [ J ]. Cancer Res, 2000,60(5) :1306-1311.
  • 4Tawfik OW, Kramer B, Shideler B, et al. Prognostic significance of CD44, platelet derived growth factor receptor al pha, and cyclooxygenase-2 expression in renal cell carcinoma [ J ]. Arch Pathol lab Med, 2007,131 (2) :261-267.
  • 5王日雄,施烯,林学德,林建华.COX-2及VEGF蛋白在大鼠乳腺癌骨移植瘤中的表达及意义[J].中国癌症杂志,2010,20(5):348-352. 被引量:7
  • 6王官成,白桂芝,袁江永.乳腺癌组织中VEGF的表达变化及意义[J].山东医药,2010,50(30):90-91. 被引量:10
  • 7滕月娥,李鹏,潘宏,刘云鹏,曲秀娟,侯科佐.117例乳腺癌组织中COX-2和VEGF-C表达及临床意义[J].现代肿瘤医学,2009,17(8):1455-1458. 被引量:5

二级参考文献26

  • 1滕月娥,李午生,金峰,刘云鹏,徐惠绵.胃癌组织COX-2、VEGF-C表达与淋巴结转移及预后关系的研究[J].中国肿瘤临床,2005,32(11):607-610. 被引量:22
  • 2项红兵,肖建斌,蔡世荣,招伟贤,董航.大鼠乳腺癌细胞移植复制胫骨癌痛模型[J].中华实验外科杂志,2006,23(8):1015-1016. 被引量:13
  • 3徐昊平,金冶宁.乳腺癌VEGF的预后及测定方法研究[J].上海交通大学学报(医学版),2007,27(4):468-471. 被引量:1
  • 4Chell S,Kadi A,Caroline A,et al.Mediators of PGE2 synthesis and signlling downstream of COX-2 represent potential targets for the prevention treatment of colorectal cancer[J].Biochim Biophys Acta,2006,1776:104-119.
  • 5Soumaoro LT,Uetake H,Takagi Y,et al.Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis[J].Dis Colon Rectum,2006,49(3):392-398.
  • 6Hirakawa S,Lawrence F,Kodama F,et al.VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites[J].Blood,2007,109:1010-1017.
  • 7Timoshenko AV,Chakraborty C,Wagner GF,et al.COX-2 -mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer[J].Bri J Cancer,2006,94:1154-1163.
  • 8Su JL,Shih JY,Yen ML,et al.Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation:A novel mechanism of lymphangiogenesis in lung adenocarcinoma[J].Cancer Research,2004,64:554-564.
  • 9Harris RE,Beebe-Donk J,Alshafie GA,et al.Reduction in the risk of human breast cancer by selective cyclooxygenase-2(COX-2) inhibitors[J].BMC Cancer,2006,6:27.
  • 10Garcia Rodriguez LA,Huerta-Alvarez C.Reduced incidence of colorectal adenoma among long-term users of nonsteroidal anti-inflammatory drug;a pooled analysis of published studies and a new population based study[J].Epidemiology,2000,11:376-378.

共引文献19

同被引文献26

  • 1薛群.COX-2在非小细胞肺癌中的表达和临床意义[J].南通大学学报(医学版),2006,26(1):16-17. 被引量:3
  • 2Bach PB. Smoking as a factor in causing lung cancer[J] . JAMA,2009,301(5):539-541.
  • 3Bartosh TJ,Ylostalo JH,Bazhanov N,et al. Dynamic compaction ofhuman mesenchymal stem/precursor cells Into spheres self-acti-vates caspase-dependent IL1 signaling to enhance secretion of mod-ulators of inflammation and Immunity ( PGE2,TSG6 and STC1 )[J].Stem Cells,2013,31 (11) :2443-2456.
  • 4Wang YC,Sung WW,Wu TC,et al. Interleukin-10 haplotype maypredict survival and relapse in resected non-small cell lung cancer. [J].PLoS 0ne,2012,7(7) :e39525.
  • 5Moore RA, Derry S, McQuay HJ. Cyclo-oxygenase-2 selectiveinhibitors and nonsteroidal anti-inflammatory drugs : balancing gas-trointestinal and cardiovascular risk [J]. BMC MusculoskeletDisord,2007,8 :73.
  • 6Pai K,Yanagawa H,Takauchi E,et al. Differential effect of inter-leukin 10 on interleulkin 12-and interleukin 2-mediated killerinduction from blood mononuclear cells[J]. Oncol Res, 1998,10(6):295-300.
  • 7Vitoriano-Souza J,Moreira Nd,Menezes-Souza D,et al. Dogs immu-nized with LBSap vaccine displayed high levels of IL-12 and IL-10cytokines and CCL4,CCL5 and CXCL8 chemokines in the dermis[J]. Mol Immunol,2013,56(4) :540-548.
  • 8许淼,李博,王杨.环氧化酶-2及其抑制剂与乳腺癌的关系[J]. 吉林医药,2005,26(4) :404-406.
  • 9Stolina M,Sharma S,Lin Y,et al. Specific inhibition of cyclooxyge-nase 2 restores antitumor reactivity by altering the balance of IL-10and IL-12 synthesis[J]. J Immunol,2000,164(1) :361-370.
  • 10Setia S, Sanyal SN. Downregulation of NF-kB and PCNA in theregulatory pathways of apoptosis by cyclooxygenase-2 inhibitors inexperimental lung cancer [J]. Mol Cell Biochem,2012,369 ( 1/2) :75-86.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部